[GENTING] YoY Annualized Quarter Result on 30-Jun-2024 [#2]

Announcement Date
29-Aug-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
30-Jun-2024 [#2]
Profit Trend
QoQ- -29.65%
YoY- 220.41%
View:
Show?
Annualized Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 28,581,528 24,963,318 19,800,612 10,379,518 10,434,312 22,037,052 20,148,142 5.99%
PBT 4,397,890 2,620,966 821,646 -1,987,892 -3,756,730 5,017,976 5,115,752 -2.48%
Tax -1,409,350 -1,135,718 -947,940 -278,838 140,622 -961,294 -1,233,822 2.23%
NP 2,988,540 1,485,248 -126,294 -2,266,730 -3,616,108 4,056,682 3,881,930 -4.26%
-
NP to SH 1,657,042 517,168 -518,430 -1,790,576 -1,836,744 2,322,638 1,972,438 -2.85%
-
Tax Rate 32.05% 43.33% 115.37% - - 19.16% 24.12% -
Total Cost 25,592,988 23,478,070 19,926,906 12,646,248 14,050,420 17,980,370 16,266,212 7.83%
-
Net Worth 34,419,039 33,269,185 31,805,956 32,614,583 34,231,835 34,770,916 33,564,816 0.41%
Dividend
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Div 462,000 462,072 539,084 - 500,578 500,578 651,372 -5.55%
Div Payout % 27.88% 89.35% 0.00% - 0.00% 21.55% 33.02% -
Equity
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Net Worth 34,419,039 33,269,185 31,805,956 32,614,583 34,231,835 34,770,916 33,564,816 0.41%
NOSH 3,850,004 3,876,896 3,876,896 3,876,896 3,876,896 3,876,896 3,858,026 -0.03%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 10.46% 5.95% -0.64% -21.84% -34.66% 18.41% 19.27% -
ROE 4.81% 1.55% -1.63% -5.49% -5.37% 6.68% 5.88% -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
RPS 742.38 648.30 514.22 269.56 270.98 572.30 525.84 5.91%
EPS 43.04 13.44 -13.46 -46.50 -47.70 60.32 51.50 -2.94%
DPS 12.00 12.00 14.00 0.00 13.00 13.00 17.00 -5.63%
NAPS 8.94 8.64 8.26 8.47 8.89 9.03 8.76 0.33%
Adjusted Per Share Value based on latest NOSH - 3,852,974
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
RPS 741.80 647.90 513.90 269.39 270.81 571.95 522.92 5.99%
EPS 43.01 13.42 -13.46 -46.47 -47.67 60.28 51.19 -2.85%
DPS 11.99 11.99 13.99 0.00 12.99 12.99 16.91 -5.56%
NAPS 8.9331 8.6347 8.2549 8.4648 8.8845 9.0244 8.7114 0.41%
Price Multiplier on Financial Quarter End Date
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Date 28/06/24 30/06/23 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 -
Price 4.71 4.06 4.54 4.93 4.10 6.77 8.41 -
P/RPS 0.63 0.63 0.88 1.83 1.51 1.18 1.60 -14.37%
P/EPS 10.94 30.23 -33.72 -10.60 -8.60 11.22 16.34 -6.46%
EY 9.14 3.31 -2.97 -9.43 -11.63 8.91 6.12 6.90%
DY 2.55 2.96 3.08 0.00 3.17 1.92 2.02 3.95%
P/NAPS 0.53 0.47 0.55 0.58 0.46 0.75 0.96 -9.41%
Price Multiplier on Announcement Date
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Date 29/08/24 24/08/23 25/08/22 27/08/21 27/08/20 29/08/19 29/08/18 -
Price 4.31 4.41 4.70 4.93 3.54 5.90 8.70 -
P/RPS 0.58 0.68 0.91 1.83 1.31 1.03 1.65 -15.97%
P/EPS 10.01 32.83 -34.91 -10.60 -7.42 9.78 16.90 -8.35%
EY 9.99 3.05 -2.86 -9.43 -13.47 10.22 5.92 9.10%
DY 2.78 2.72 2.98 0.00 3.67 2.20 1.95 6.08%
P/NAPS 0.48 0.51 0.57 0.58 0.40 0.65 0.99 -11.35%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment